Wavepaths develops adaptive music-based therapeutic platforms designed to support mental health interventions. The company’s technology delivers person-centered, dynamically generated music intended to enhance experiences in psychedelic therapy, ketamine-assisted sessions, breathwork, and psychotherapy. Its approach focuses on shaping the therapeutic environment to promote emotional processing and engagement. Wavepaths positions its platform within mental health care and experiential therapy contexts.

The technology uses adaptive algorithms to generate and modulate music in real time, responding to session dynamics and individual patient needs. Music is tailored to support emotional, cognitive, and physiological states, creating an immersive therapeutic context. By aligning musical elements with therapeutic objectives, the system aims to enhance engagement, insight, and emotional integration. The platform emphasizes personalization and dynamic responsiveness rather than passive listening.

Wavepaths targets clinicians, therapists, and facilitators delivering psychedelic-assisted therapy, ketamine sessions, and other experiential mental health interventions. The platform is intended to complement guided therapy rather than replace standard clinical care. Its positioning reflects growing recognition of music as a scalable, person-centered adjunctive tool in modern psychotherapeutic practices.